Mounjaro 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM6S6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,537
Award facts
- Contract value 100% obligated
- $10,536.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,536.80 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 15 mg/0.5 mL pens on December 12, 2025, with completion scheduled for December 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award criteria. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a broad range of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet diverse medical procurement requirements through open competition, with previous delivery orders covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. Mounjaro is a GLP-1 receptor agonist used for diabetes management, and this delivery order represents routine pharmaceutical resupply under the established prime vendor contract structure that enables flexible procurement of critical medical commodities across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FM6S6?
SPE2DR26FM6S6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FM6S6 worth?
The government has obligated $10,537 on SPE2DR26FM6S6.
Is contract SPE2DR26FM6S6 an order under another contract?
Yes. SPE2DR26FM6S6 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM6S6 competed?
The extent of competition for SPE2DR26FM6S6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award